The influence of crystal habit on the prediction of dry powder inhalation formulation performance using the cohesive-adhesive force balance approach

Drug Development and Industrial Pharmacy

Volumn 34, Issue 9, 2008, Pages 974-983

  Hooton, Jennifer C ^a   Jones, Matthew D ^a   Harris, Haggis ^a   Shur, Jagdeep ^a   Price, Robert ^a  

^a University of Bath   (United Kingdom)

Author keywords

Atomic force microscopy; Budesonide; CAB; Crystal face

Indexed keywords

BETA CYCLODEXTRIN; BUDESONIDE; LACTOSE; RAFFINOSE; TREHALOSE; XYLITOL;

ADHESION; ARTICLE; ATOMIC FORCE MICROSCOPY; CRYSTAL; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; POWDER INHALER;

ADHESIVENESS; BUDESONIDE; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; MICROSCOPY, ATOMIC FORCE; MODELS, MOLECULAR; NEBULIZERS AND VAPORIZERS; POWDERS;

EID: 52149123694     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802149087     Document Type: Article

References (15)

1. Albertsson, J., Oskarsson, A., & Svensson, C. (1978). X-ray study of budesonide: Molecular structure and solid solutions of the (22S) and (22R) epimers of 11 beta, 21-dihydroxy-16alpha-propylmethylenedioxy-1,4-pregnadiene-3, 20-dione. Acta. Cryst. B., 34, 3027-3036.
2. Begat, P., Morton, D., Staniforth, J., & Price, R. (2004). The cohesive-adhesive balances in dry powder inhaler formulations I: Direct quantification by atomic force microscopy. Pharm. Res., 21(9), 1591-1597.
3. Blagden, N., Davey, R. J., Lieberman H. F., Williams, L., Payne, R., Roberts, R., Rowe, R., & Docherty, R. (1998). Crystal chemistry and solvent effects in polymorphic systems Sulfathiazole. J. Chem. Soc., Faraday. Trans., 94(8), 1035-1044.
4. Cline, D., & Dalby, R. (2002). Predicting the quality of powders for inhalation from surface energy and area. Pharm. Res., 19(9), 1274-1277.
5. Harjunen, P., Lankinen, T., Salonen, H., Lehto, V., & Jarvinen, K. (2003). Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI. Int. J. Pharm., 263, 151-163.
6. Hooton, J. C., Jones M. D., & Price, R. (2006). Predicting the behaviour of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach. J. Pharm. Sci., 95(6), 1288-1297.
7. Kretchmer, N. (1972). Lactose and lactase. Sci. Am., 227(4), 74-78.
8. Mullin, J. W. (2001). Crystallization (4th ed.). Oxford: Butterworth-Heinemann.
9. Muster, T. H., & Prestidge, C. A. (2002). Face specific surface properties of pharmaceutical crystals. J. Pharm. Sci., 91(6), 1432-1444.
10. Steckel, H., & Bolzen, N. (2004). Alternative sugars as potential carriers for dry powder inhalation. Int. J. Pharm., 270, 297-306.
11. Tee, S. K., Marriott, C., Zeng, X. M., & Martin, G. P. (2000). The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate. Int. J. Pharm., 208, 111-123.
12. Wells, A. F. (1946). Crystal habit and internal structure. Philos. Mag., 37, 184-199.
13. Zeng, X. M., Martin, G. P., & Marriott, C. (1995). The controlled delivery of drugs to the lung. Int. J. Pharm., 124, 149-164.
14. Zeng, X. M., Martin, G. P., Marriott, C., & Pritchard, J. (2000a). The influence of carrier morphology on drug delivery by dry powder inhalers. Int. J. Pharm., 200, 93-106.
15. Zeng, X. M., Martin, G. P., Marriott. C., & Pritchard, J. (2000b). The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates. J. Pharm. Pharmacol., 52, 1211-1221.